Skip to Main Content

Full Prescribing Information
Patient Information
For Healthcare Professionals

NOW APPROVED

ETCAMAH is expected to be available in September 2026.

Please see full Prescribing Information, including Boxed WARNING, and Patient Information.

Contact Us AstraZeneca Corporate Site Privacy Notice Cookie Preferences Legal Statement Accessibility Statement Your Privacy Choices

Site Map Consumer Health Data Privacy Notice

This product information is for United States residents only.

ETCAMAH is a registered trademark of the AstraZeneca group of companies.

©2026 AstraZeneca. All rights reserved.

US-101843 Last Updated 8/26

You are about to enter the ETCAMAH HCP site for healthcare professionals.

The information on this site is intended for US healthcare professionals only.

Go Back